...exist on the public markets. This serves to limit access to much needed investment when investor confidence in the sectorslumps. The report calls for amendment of the pre-emption guidelines to permit UK-listed life science companies to issue...
http://www.newsco.com/productsandservices/archive/mbi/2004-01/biocitylives